Skip to main content
Clinical Trials/CTRI/2024/07/071199
CTRI/2024/07/071199
Not yet recruiting
未知

A cross sectional, non-randomized clinical performance study to collect the data using Vivaray Hb pro and use the device generated hemoglobin value for validation by comparing it with the hemoglobin value generated from the gold standard (calibrated blood cell counter). - NI

Bosch Global Software Technologies Pvt. Ltd.0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: R799- Abnormal finding of blood chemistry, unspecifiedHealth Condition 2: R799- Abnormal finding of blood chemistry, unspecified
Sponsor
Bosch Global Software Technologies Pvt. Ltd.
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Sponsor
Bosch Global Software Technologies Pvt. Ltd.

Eligibility Criteria

Inclusion Criteria

  • 1\. Male or Female patients with age of greater than eight (8\) years
  • 2\. Range of Hemoglobin 4\-18 g/dl.
  • 3\. Able to give written informed consent, assent or parents’ consent form.
  • 4\. Finger size: 8 mm to 23 mm (The device is designed to fit fingers in this range) and index finger preferred to capture the signal.

Exclusion Criteria

  • 1\. Patients with paronychia, fungal infections of the nail bed, blistering disorders involving the fingers, hyper\-keratosis, nail polish, mehendi and callus formation on nail.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Wound healing properties of a topical wound healing producthealthy volunteersintended indication is the treatment of acute wounds such as abrasions, cuts, scratches, laceration, blistering burns and sunburnsTherapeutic area: Not possible to specify
EUCTR2014-001374-34-DEMEDICE Arzneimittel Pütter GmbH & Co. KG
Completed
Phase 2
Prospective, non-randomized, non-blinded clinical trial of granulocyte colony-stimulating factor for acute spinal cord injuryspinal cord injury
JPRN-UMIN000024521Ministry of Health, Labour and Welfare60
Recruiting
Not Applicable
An epidemiological, non-interventional study to determine the prevalence of clinical Subtypes of Constipation in INdian patients.
CTRI/2015/01/005470Abbott India Limited920
Active, not recruiting
Not Applicable
A prospective, non-randomised, non-controlled, open label, multicentre phase II study: PTK 787/ZK222584 in patients with advanced neuroendocrine tumours - PTK878/ZK 222584 in patients with advanced NETeuroendocrine Tumour
EUCTR2004-002420-18-GBCHARITE Universitätsmedizin Berlin Campus Virchow-Klinikum35
Recruiting
Phase 1
A prospective, observer-blind, randomized clinical trial to investigate and compare the clinical efficacy of Chloroprocaine 3% gel and Oxybuprocaine 0.4% eye drops anesthesia for clinical practice in pediatric population.male/female outpatients, aged 0-17 years scheduled to undergo ocular exams with a need of ocular surface anesthesia.Therapeutic area: Diseases [C] - Eye Diseases [C11]
CTIS2023-504477-21-01Sintetica S.A.74